Our research aims at developing new symptomatic and disease-modifying treatments for disorders of basal ganglia origin, particularly Parkinson´s Disease (PD). To facilitate this research, we have pioneered the development of rodent models having both face and construct validity relative to dyskinetic and akinetic movement disorders in humans. These models have now become the first-line tool for behavioural-pharmacological research on PD worldwide. We are now in the process of developing new rodent models of cognitive deficits and impulse control disorders relevant to PD. In addition to developing-improving rodent models for translational research, we investigate maladaptive neuroplasticity associated with movement disorders, and we do so at multiple levels and with multiple methodologies (e.g., signaling-pathway activation, synaptic neuronal plasticity, gliovascular plasticity and neurovascular coupling).  

Current commissions of trust 

2016         International Parkinson and Movement Disorder Society, Scientific Program Committee.

2016         Swedish National Microscopy Infrastructure, Steering Committee.

2015         Swedish Brain Foundation, Scientific Committee.

2014         SciLifeLab Bioimaging Platform (Stockholm), Steering Board.

2014         Elected as a member of the FENS Committee for Higher Education and Training (CHET).

2014         External Scientific Advisory Board for “Cell Signaling in Chronic CNS Disorders” (Austria)

2014         Lund University Medical Faculty, Scientific Advisory Committee.

2014         World Parkinson Congress, Steering Committee.

2014         XXI World Congress on PD and Related Disorders, Program Committee.

2013         International Parkinson and Movement Disorder Society, Chair. 

2012         International Brain Research Organization (IBRO), Paneuropean Committee.

2010         M. J. Fox Foundation for Parkinson´s Research, Scientific Advisory Board.

2009         Swedish National Network for Parkinson Research (SWEPAR-Net), Steering board. 

2009         Steering Committee of Basal Ganglia Disorders Linnaeus Consortium (BAGADILICO).

2003         Swedish Movement Disorder Society (SWEMODIS), Steering Board (and founding member).

Completed commissions of trust: 

2015         Swedish Research Council, Chair of Scientific Review Panel MH-D1 (Neurology & Neuroscience).

2013         Chair of the External Evaluation Panel for Departments of Neurosciences, Neurology, Ophtalmology and Otorhinolaryngology, KU Leuven (Belgium).

2012-2014  Coordinator of Basal Ganglia Disorders Linnaeus Consortium (BAGADILICO)